British health officials acknowledged today that restrictions due to the pandemic could be lifted in June after a The study concluded that the Pfizer and AstraZeneca vaccines provide effective protection against the variant that originated in India..
In recent weeks, British authorities have expressed concern about the increase in cases of this alternative in the UK, which could hurt the inflation reduction plan.
According to the latest data, more than 2,800 cases of covid-19 infection of the type detected in India have been recorded in England.
The British government has stated that the Indian variant appears to be more portable, but doubts remain about the severity.
UK Health Safety Agency Executive Director Jenny Harries said today that British authorities are on their way to move forward with the final phase of the scale removal plan from June 21, if residents remain cautious.
“People must continue to maintain all safety rules,” Jenny Harries told the BBC, warning that this alternative has become dominant in some parts of northern England, and residents in this region must be vigilant.
Health Secretary Matt Hancock also said he was “increasingly confident” that England would be able to follow through with its plans to remove the missiles.
The statements by these two officials come after an investigation by Public Health England (PHE) that found that two doses of the vaccine from Pfizer or AstraZeneca provide “high levels of protection” against asymptomatic diseases of the type discovered in India.
According to the study, conducted between April 5 and May 16, Pfizer’s formula was 88% effective against accidental disease caused by the mutation detected in India two weeks after the second dose, versus 93% efficacy compared to the discovery in England.
Experts found that in the case of AstraZeneca / University of Oxford, the vaccine was 60% effective against the variant detected in India, compared to 66% of the variant detected in the UK (Kent variant).